Home   Logon   Mobile Site   Research and Commentary   About Us   Call 1.800.621.1675 or Email Us       Follow Us: 

Search by Ticker, Keyword or CUSIP       
 
 
 
Blog Home
Bob Carey
Chief Market Strategist
Click for Bio

Follow Bob on Twitter Follow Bob on LinkedIn View Videos on YouTube
 

  US Stock Markets Ended Dec. 24, 2020
Posted Under: Weekly Market Commentary
Supporting Image for Blog Post

 
The S&P 500 moved slightly lower during the holiday-shortened week as investors weighed a likely stimulus deal with a new variant of the coronavirus in the U.K. that spreads faster and could make vaccines less effective. Financials and technology were the best performing sectors for the week. Banks gained after passing the latest stress test with flying colors. In an unexpected move, the Federal Reserve allowed profitable banks to resume share buybacks, though dividends are still capped at current levels. JP Morgan Chase & Co. quickly announced a $30 billion share buyback. Technology stocks moved higher on news that Apple Inc. is entering into the self-driving car market and a surge in cybersecurity stocks due to the widespread Russian hack. Fireye Inc. initially fell by over 10% after disclosing the hack of its network but then surged over 50% as many other firms were also hacked, which is likely to drive incremental demand for their solutions. Work-from-anywhere also climbed to new heights as rolling lockdowns continue around the globe and cases remain high in the near term until the vaccines can be more widely distributed. Tesla Inc. entered the S&P 500 after Friday's close on December 18th as the 6th largest weight. Shares of the electric-vehicle maker went parabolic before being added to the major index, gaining 730% for the year and 70% since the announcement of inclusion on November 16th.  However, shares fell by nearly 5% during its first week in the index. While the short run has more uncertainty due to COVID-19, the longer term looks more promising with the U.S. signing a bigger agreement for vaccine doses with Pfizer Inc. Additionally, continued loose monetary policy and a reopening of the economy could be a powerful one-two punch for equities into 2021.
Posted on Monday, December 28, 2020 @ 8:33 AM • Post Link Share: 
Print this post Printer Friendly

These posts were prepared by First Trust Advisors L.P., and reflect the current opinion of the authors. They are based upon sources and data believed to be accurate and reliable. Opinions and forward looking statements expressed are subject to change without notice. This information does not constitute a solicitation or an offer to buy or sell any security.
Search Posts
MARKET ANALYSIS
Market Commentary and Analysis
Market Commentary Video
Weekly Market Commentary
Weekly Market Watch
Monthly Talking Points
Quarterly Newsletter
Market Observations
Subscribe To Receive Email
 


 PREVIOUS POSTS
US Economy and Credit Markets Ended Dec. 24, 2020
US Stock Markets Ended Dec. 18, 2020
US Economy and Credit Markets Ended Dec. 18, 2020
Commodity Prices Rising As The U.S. Dollar Falls
A 20-Year Snapshot Of Bond Yields
US Stock Markets Ended Dec. 11, 2020
US Economy and Credit Markets Ended Dec. 11, 2020
The Pop In Treasury Returns Likely Not Sustainable
A Snapshot of Growth vs. Value Investing
US Stock Markets Ended Dec. 4, 2020
Archive
Skip Navigation Links.
Search by Topic
Skip Navigation Links.

 
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
First Trust Portfolios L.P.  Member SIPC and FINRA. (Form CRS)   •  First Trust Advisors L.P. (Form CRS)
Home |  Important Legal Information |  Privacy Policy |  California Privacy Policy |  Business Continuity Plan |  FINRA BrokerCheck
Copyright © 2022 All rights reserved.